DUN T1
Orally Administered Drug for Type-1 Diabetes
Active
Seed
Startup
Meishar
Founded 2017-07
DUN T1 is an early-stage R&D company that develops an orally administered drug for type 1 diabetes. DUN T1's vision is to develop a proactive approach towards treatment and early diagnosis. DUN T1's novel natural ingredient is patented, safe, and effective.
SectorHealth Tech & Life Sciences
StageSeed
Total raised$45K
Employees3
Founded2017-07
HQMeishar
Patents1
Confidence85
Sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Target customers
Commerce & RetailDistribution ChannelsDistributorHealthcare & Life SciencesLife SciencesPharmaceuticals